Literature DB >> 11008191

The role of D1-dopamine receptors in working memory-guided movements mediated by frontal cortical areas.

.   

Abstract

Like the striatum, the frontal motor cortices receive dopaminergic fibers from midbrain dopamine cells and contain high levels of dopamine receptors. Among frontal cortical areas, the dorsolateral PFC (PFd1) and the dorsal premotor cortex (PMd) have strong neural connections and play a major role for working memory-guided directional movements. To reveal the role of dopamine in this cognitive motor function, dopamine antagonists (SCH23390 for D1 receptors and sulpiride for D2 receptors) were applied locally or iontophoretically to the PFd1 and PMd in monkeys that performed delayed-response tasks with memory-guided directional movements. Applications of SCH23390, but not sulpiride, to these areas had significant effects at both the behavioral and neuronal levels. In the PFd1 and at the behavioral level, local injections of SCH23390 induced specific errors for memory-guided saccades, whereas it had no effects on visually guided saccades. In the PMd, local injections of SCH23390 induced directional errors and increased reaction time and movement time in memory-guided reaching movements. At the neuron level, iontophoretic applications of SCH23390 attenuated directional tuning of neurons of the PFd1 and PMd, which showed directional activities during the delay-and/or response-period(s). These findings suggest that the activation of D1-dopamine receptors in these frontal cortical areas plays a facilitating role in a series of neuronal processes of working memory-guided directional movements; the working memory process for guiding motor act in the PFd1 and preparation/control of directional manual movements in the PMd. In addition, our findings may provide insight into symptoms of schizophrenia and Parkinson's disease; the dysfunction of D1-dopamine receptors in the PMd1 and PMd may contribute to some symptoms, such as bradyphrenia and bradykinesia, in these disorders.

Entities:  

Year:  2000        PMID: 11008191     DOI: 10.1016/s1353-8020(00)00044-4

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  11 in total

Review 1.  Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

Authors:  Yunqi Xu; Junqiang Yan; Peng Zhou; Jiejie Li; Huimin Gao; Ying Xia; Qing Wang
Journal:  Prog Neurobiol       Date:  2012-02-25       Impact factor: 11.685

Review 2.  Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders.

Authors:  Nao J Gamo; Amy F T Arnsten
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

3.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

4.  Cortical activity in Parkinson's disease during executive processing depends on striatal involvement.

Authors:  Oury Monchi; Michael Petrides; Beatriz Mejia-Constain; Antonio P Strafella
Journal:  Brain       Date:  2006-11-21       Impact factor: 13.501

5.  Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice.

Authors:  Julie Deguil; François Chavant; Claire Lafay-Chebassier; Marie-Christine Pérault-Pochat; Bernard Fauconneau; Stéphanie Pain
Journal:  Neurotox Res       Date:  2009-07-21       Impact factor: 3.911

6.  Dopamine D2 receptor occupancy levels of acute sulpiride challenges that produce working memory and learning impairments in healthy volunteers.

Authors:  Mitul A Mehta; Andrew J Montgomery; Yuri Kitamura; Paul M Grasby
Journal:  Psychopharmacology (Berl)       Date:  2007-10-03       Impact factor: 4.530

7.  Effects of morphine and naltrexone on impulsive decision making in rats.

Authors:  Artur K Kieres; Kathryn A Hausknecht; Andrew M Farrar; Ashley Acheson; Harriet de Wit; Jerry B Richards
Journal:  Psychopharmacology (Berl)       Date:  2004-01-30       Impact factor: 4.530

8.  Frontostriatal cognitive staging in Parkinson's disease.

Authors:  Raúl de la Fuente-Fernández
Journal:  Parkinsons Dis       Date:  2011-12-06

9.  Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD.

Authors:  Raúl de la Fuente-Fernández
Journal:  Front Neurol       Date:  2013-07-09       Impact factor: 4.003

10.  Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO.

Authors:  Amane Tateno; Takeshi Sakayori; Woo-Chan Kim; Kazuyoshi Honjo; Haruo Nakayama; Ryosuke Arakawa; Yoshiro Okubo
Journal:  Int J Neuropsychopharmacol       Date:  2018-06-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.